Cécile L. Berends

Phase 1 clinical trial of losmapimod in facioscapulohumeral dystrophy: Safety, tolerability, pharmacokinetics, and target engagement

Michelle Mellion, Lucienne Ronco, Cécile L. Berends et al. · British Journal of Clinical Pharmacology · 2021 · 39 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +7

MicroRNA‐122 can be measured in capillary blood which facilitates point‐of‐care testing for drug‐induced liver injury

A. D. Bastiaan Vliegenthart, Cécile L. Berends, Carmelita M. J. de Potter et al. · British Journal of Clinical Pharmacology · 2017 · 37 citations · Full text

Life Sciences, Molecular Biology, Molecular Medicine +16

Characterization of Triptolide-Induced Hepatotoxicity by Imaging and Transcriptomics in a Novel Zebrafish Model

A. D. Bastiaan Vliegenthart, Chunmin Wei, Charlotte Buckley et al. · Toxicological Sciences · 2017 · 28 citations · Full text

Pharmacy, Molecular Biology, Toxicology +17

First‐in‐human trial to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of STR‐324, a dual enkephalinase inhibitor for pain management

Laurence Moss, Cécile L. Berends, Emilie M.J. van Brummelen et al. · British Journal of Clinical Pharmacology · 2021 · 13 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +16

Validation of a pharmacological model for mitochondrial dysfunction in healthy subjects using simvastatin: A randomized placebo-controlled proof-of-pharmacology study

Marcus P.J. van Diemen, Cécile L. Berends, Joep Wezel et al. · European Journal of Pharmacology · 2017 · 12 citations

Life Sciences, Pharmacology, Clinical Pharmacology +11